retatrutide vs tirzepatide trial vs. Tirzepatide: The Next-Gen GLP-1 Showdown Retatrutide vs. tirzepatide: how they're
Description
The SELECT trial (NEJM, 2023) showed a 20% reduction in major cardiovascular events in patients taking semaglutide
Patches claiming GLP-1 delivery produce nothing measurable at all
Seemayer C
Some papers found effects (Parmley et al
In plain terms: the risk is real and label-acknowledged, but it concentrates in people who get dehydrated, not the whole population
Every U-100 insulin syringe follows this standard
